Polatuzumab vedotin combined with bendamustine and rituximab for relapsed/refractory diffuse large B-cell lymphoma: A systematic review protocol

• Mohammadreza Eslami,

  Roles Conceptualization, Methodology, Writing – original draft

  Affiliations Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran, School of paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran

  https://orcid.org/0000-0002-6439-9431

  ⨯
• Mahdi Mehrabi,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliations Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran, School of paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran

  ⨯
• Mehrdad Payandeh,

  Roles Methodology, Supervision

  Affiliation Department of Internal medicine, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

  ⨯
• Fakhredin Saba

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  * E-mail: saba.fakhredin@gmail.com

  Affiliation School of paramedical, Kermanshah University of Medical Sciences, Kermanshah, Iran

  ⨯